View Financial HealthCirChem 配当と自社株買い配当金 基準チェック /06CirChem配当金を支払った記録がありません。主要情報n/a配当利回り-33.3%バイバック利回り総株主利回り-33.3%将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • Nov 17CirChem AB (publ), Annual General Meeting, May 19, 2026CirChem AB (publ), Annual General Meeting, May 19, 2026.お知らせ • May 29CirChem AB (publ) has filed a Follow-on Equity Offering in the amount of SEK 13.401946 million.CirChem AB (publ) has filed a Follow-on Equity Offering in the amount of SEK 13.401946 million. Security Name: Shares Security Type: Common Stock Securities Offered: 6,700,973 Price\Range: SEK 2 Transaction Features: Rights Offeringお知らせ • Apr 14CirChem AB (publ), Annual General Meeting, May 21, 2025CirChem AB (publ), Annual General Meeting, May 21, 2025, at 10:30 W. Europe Standard Time. Location: at convendum`s premises, vasagatan 16, stockholm SwedenReported Earnings • Aug 18Second quarter 2024 earnings released: kr0.095 loss per share (vs kr0.16 loss in 2Q 2023)Second quarter 2024 results: kr0.095 loss per share (improved from kr0.16 loss in 2Q 2023). Revenue: kr3.72m (up 292% from 2Q 2023). Net loss: kr2.77m (loss narrowed 41% from 2Q 2023). Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 47% per year, which means it is significantly lagging earnings.New Risk • Jun 20New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.6% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (14% average weekly change). Earnings have declined by 19% per year over the past 5 years. Revenue is less than US$1m (kr8.9m revenue, or US$856k). Market cap is less than US$10m (€7.24m market cap, or US$7.77m). Minor Risk Shareholders have been diluted in the past year (3.6% increase in shares outstanding).Reported Earnings • May 05Full year 2023 earnings released: kr0.59 loss per share (vs kr1.42 loss in FY 2022)Full year 2023 results: kr0.59 loss per share (improved from kr1.42 loss in FY 2022). Revenue: kr6.90m (up 72% from FY 2022). Net loss: kr17.1m (loss narrowed 25% from FY 2022). Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 48% per year, which means it is significantly lagging earnings.Reported Earnings • Nov 24Third quarter 2023 earnings releasedThird quarter 2023 results: Net loss: kr3.71m (loss widened 2.7% from 3Q 2022).Reported Earnings • Aug 28Second quarter 2023 earnings releasedSecond quarter 2023 results: Net loss: kr4.70m (loss narrowed 32% from 2Q 2022).Reported Earnings • May 22First quarter 2023 earnings releasedFirst quarter 2023 results: Net loss: kr6.91m (loss widened 21% from 1Q 2022).Reported Earnings • Feb 10Full year 2022 earnings released: kr1.32 loss per share (vs kr1.42 loss in FY 2021)Full year 2022 results: kr1.32 loss per share. Revenue: kr4.11m (up 48% from FY 2021). Net loss: kr22.7m (loss widened 25% from FY 2021).Board Change • Dec 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Chairman of the Board Mats Persson was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Nov 24Third quarter 2022 earnings releasedThird quarter 2022 results: Revenue: kr1.70m (up 434% from 3Q 2021). Net loss: kr3.62m (loss narrowed 30% from 3Q 2021).Reported Earnings • May 30First quarter 2022 earnings released: kr0.36 loss per share (vs kr0.37 loss in 1Q 2021)First quarter 2022 results: kr0.36 loss per share. Net loss: kr5.72m (loss widened 22% from 1Q 2021).Reported Earnings • Apr 06Full year 2021 earnings released: kr1.42 loss per share (vs kr0.94 loss in FY 2020)Full year 2021 results: kr1.42 loss per share (down from kr0.94 loss in FY 2020). Net loss: kr18.2m (loss widened 91% from FY 2020).Reported Earnings • Aug 20Second quarter 2021 earnings releasedSecond quarter 2021 results: Net loss: kr3.43m (down 376% from profit in 2Q 2020).決済の安定と成長配当データの取得安定した配当: CRBの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: CRBの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場CirChem 配当利回り対市場CRB 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (CRB)n/a市場下位25% (DE)1.5%市場トップ25% (DE)4.6%業界平均 (Chemicals)3.7%アナリスト予想 (CRB) (最長3年)n/a注目すべき配当: CRBは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: CRBは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: CRBの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: CRBが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YDE 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/14 07:48終値2026/05/14 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋CirChem AB (publ) 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Nov 17CirChem AB (publ), Annual General Meeting, May 19, 2026CirChem AB (publ), Annual General Meeting, May 19, 2026.
お知らせ • May 29CirChem AB (publ) has filed a Follow-on Equity Offering in the amount of SEK 13.401946 million.CirChem AB (publ) has filed a Follow-on Equity Offering in the amount of SEK 13.401946 million. Security Name: Shares Security Type: Common Stock Securities Offered: 6,700,973 Price\Range: SEK 2 Transaction Features: Rights Offering
お知らせ • Apr 14CirChem AB (publ), Annual General Meeting, May 21, 2025CirChem AB (publ), Annual General Meeting, May 21, 2025, at 10:30 W. Europe Standard Time. Location: at convendum`s premises, vasagatan 16, stockholm Sweden
Reported Earnings • Aug 18Second quarter 2024 earnings released: kr0.095 loss per share (vs kr0.16 loss in 2Q 2023)Second quarter 2024 results: kr0.095 loss per share (improved from kr0.16 loss in 2Q 2023). Revenue: kr3.72m (up 292% from 2Q 2023). Net loss: kr2.77m (loss narrowed 41% from 2Q 2023). Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 47% per year, which means it is significantly lagging earnings.
New Risk • Jun 20New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.6% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (14% average weekly change). Earnings have declined by 19% per year over the past 5 years. Revenue is less than US$1m (kr8.9m revenue, or US$856k). Market cap is less than US$10m (€7.24m market cap, or US$7.77m). Minor Risk Shareholders have been diluted in the past year (3.6% increase in shares outstanding).
Reported Earnings • May 05Full year 2023 earnings released: kr0.59 loss per share (vs kr1.42 loss in FY 2022)Full year 2023 results: kr0.59 loss per share (improved from kr1.42 loss in FY 2022). Revenue: kr6.90m (up 72% from FY 2022). Net loss: kr17.1m (loss narrowed 25% from FY 2022). Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 48% per year, which means it is significantly lagging earnings.
Reported Earnings • Nov 24Third quarter 2023 earnings releasedThird quarter 2023 results: Net loss: kr3.71m (loss widened 2.7% from 3Q 2022).
Reported Earnings • Aug 28Second quarter 2023 earnings releasedSecond quarter 2023 results: Net loss: kr4.70m (loss narrowed 32% from 2Q 2022).
Reported Earnings • May 22First quarter 2023 earnings releasedFirst quarter 2023 results: Net loss: kr6.91m (loss widened 21% from 1Q 2022).
Reported Earnings • Feb 10Full year 2022 earnings released: kr1.32 loss per share (vs kr1.42 loss in FY 2021)Full year 2022 results: kr1.32 loss per share. Revenue: kr4.11m (up 48% from FY 2021). Net loss: kr22.7m (loss widened 25% from FY 2021).
Board Change • Dec 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Chairman of the Board Mats Persson was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Nov 24Third quarter 2022 earnings releasedThird quarter 2022 results: Revenue: kr1.70m (up 434% from 3Q 2021). Net loss: kr3.62m (loss narrowed 30% from 3Q 2021).
Reported Earnings • May 30First quarter 2022 earnings released: kr0.36 loss per share (vs kr0.37 loss in 1Q 2021)First quarter 2022 results: kr0.36 loss per share. Net loss: kr5.72m (loss widened 22% from 1Q 2021).
Reported Earnings • Apr 06Full year 2021 earnings released: kr1.42 loss per share (vs kr0.94 loss in FY 2020)Full year 2021 results: kr1.42 loss per share (down from kr0.94 loss in FY 2020). Net loss: kr18.2m (loss widened 91% from FY 2020).
Reported Earnings • Aug 20Second quarter 2021 earnings releasedSecond quarter 2021 results: Net loss: kr3.43m (down 376% from profit in 2Q 2020).